Contribution of 3D Modeling in Surgical Management of Pediatric Retroperitoneal and Pelvic Tumors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3-17
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
This study's purpose is the comparison of the automatically segmented 3D model to the reference manual segmentation, based on the Dice precision index. It is implemented by making parents' patients, surgeons and surgical helpers answer specific questions comparing 3D images to usual 2D images of the patient's tumor.
Eligibility criteria
Qualifiers
Children between 3 months and less than 18 years old
Children with a pelvic tumor requiring an MRI for a possible surgical intervention
Children with a retroperitoneal tumor requiring a CT scan or MRI with a view to surgical intervention
Children with no contraindication for a CT scan and/or 3T MRI
Disqualifiers
Contraindication to MRI: metallic ocular foreign body, pacemaker, mechanical heart valve, old vascular clips on cerebral aneurysm
Need for an MRI under general anaesthesia
Contraindication for a CT scan with injection: renal failure, allergy to iodinated contrast products
Patients having participated in a therapeutic clinical trial involving a new molecule within 30 days before inclusion
Trial design
Treatments tested in this trial
- Not listed
Trial groups
60 Participants
are grouped into 1 trial groupSponsors and collaborators
Assistance Publique - Hôpitaux de Paris
Lead sponsor
Imagine Institute
Collaborator
Ligue contre le cancer, France
Collaborator
URC-CIC Paris Descartes Necker Cochin
Collaborator
Source ClinicalTrials.gov